Uterine fibroids are the most common form of benign pelvic tumor, with about 30-50% of women between the ages of 35-45 years reporting them. Although many women are asymptomatic, those who experience the symptoms of bladder pressure, frequent and very heavy menstrual periods, and uterine pain, have a reduced quality of life.
Andrea Martini and Joerg Larsen, of the Institute for Roentgendiagnostics, Braunschweig Teaching Hospitals, Germany, discuss nanotechnology, hybrid imaging and the quest for a personalised medicine.
Amyloidb (Ab) plaque formation is a hallmark of Alzheimers disease (AD) and precedes the onset of dementia. Australian researchers reported the first data on the validity in humans of a new PET tracer binding to Ab. Their data suggest that 18F-BAY94-9172 of Bayer Schering Pharma AG can reliably detect Ab deposition and thereby aid early diagnosis, differential diagnosis, and therapeutic…
The Uliazpi Foundation in Spain, which studies and cares for severely mentally retarded patients, carried out an interesting study to identify bone mineral density values in a group of its patients, compare these with the general population and investigate the possible influence on these values on certain clinical variables and therapeutic regimens.
The Milano Convention Centre (MIC) is the largest of its kind in Italy. Certainly that space will prove valuable this March, when 9,500 urologists from 100 countries attend the 23rd EAU Congress, the second biggest of its kind in the world. Apart from attending the congress and related trade fair, they may also glimpse Milan's many attractions: the cathedral, La Scala, Sforza's Castle, or even…
As part of a research and development project, doctors at the University Hospital Magdeburg, Germany, are treating oncology patients with local minimally invasive surgery (MIS) which, for the first time, can be carried out under radiological image control using high-field magnetic resonance imaging (MRI). The system offers excellent image quality under extremely favourable, radiation-free…
By Professor Jean-Charles Preiser MD PhD, of the Department of General Intensive Care, University Hospital Centre, University of Liege, Belgium
By Rudolf Schwarz and Andreas Krüll, of the Section of Radiation Oncology Department, Ambulanzzentrum GmbH of the University Medical Center Hamburg-Eppendorf
Molecular imaging aims at the in vivo quantitative visualisation of molecules and molecular events that occur at cellular level. The potential towards clinical translation is huge, because the same modalities used in medical imaging are used in molecular imaging investigations.
Advanced Research Technologies Inc. ("ART") announced the first sale of SoftScan® optical breast imaging system to the Sunnybrook Health Sciences Centre ('Sunnybrook") in Toronto, Canada. Sunnybrook is the first health centre to purchase a SoftScan imaging system since the Canadian company received regulatory approval for commercialization in Europe and Canada for its optical breast imaging…
The upper gastrointestinal (UGI) team at Milton Keynes Hospital NHS Foundation Trust has developed a rapid access service for upper gastrointestinal cancers. The new system means that patients are referred directly from their GP to the hospital for an endoscopy.
During a workshop organized by the European Science Foundation (ESF), researchers discussed further steps in developing computerised “in-silico” models of the heart that simulate the real heart and enable possible drugs and therapies to be tested without risk to people.
Patients with severe COPD may benefit more from therapy that combines salmeterol and fluticasone [SFC] than treatment with tiotropium, according to results from a long-term, multi-center study, “Investigating New Standards for Prophylaxis in Reducing Exacerbations” (INSPIRE) that directly compared the two therapies.
The collaboration between two companies may pave the way for the development of new therapy options for neuroendocrine tumors: Covidien LTd, a global provider of healthcare products and BioSynthema Inc., a company specialized in the discovery and development of molecular targeted biophamaceuticals recently signed an agreement that will gain BioSynthema access to specific Covidien proprietary…
Presented during a symposium at Langenbeck-Virchow-Haus, in Berlin, the European CLINICIP research project aims to develop a method to improve glycaemic control during intensive care and provide a low-risk monitoring and control system that can control the metabolism of the critically ill
UK - Optical imaging company Michelson Diagnostics Ltd (MDL) has announced successful initial results from clinical testing of its novel optical coherence tomography (OCT) imaging technology. The tests, performed on cancerous and precancerous human oesophagus and lymph node tissue, were designed to establish the potential value of MDL's optical imaging technology used during cancer surgery.
A British collaboration has secured £325,000 (?460,000) of government backing to develop an in vivo optical imaging probe for diagnostic and therapeutic applications in oncology. The long-term objective is to use optical coherence tomography (OCT), an interferometric imaging modality, to perform real-time diagnosis and to guide the removal of cancerous or precancerous tissue during the same…
Enzymes are biocatalysts that control the different metabolic processes of living organisms. These range from digestion to the copying of genetic information.
Over 15 million people are affected by strokes annually, and about five million of these (source: WHO 2004) are left with lasting damage.
In Europe, more than ten million people suffer from diabetes mellitus, 90 percent of whom have diabetes type II.
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
The uses of the internet in psychiatry have increased in recent years, and there is evidence that professionals, patients, families, institutions and other agents benefit from it.
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
The first European Multidisciplinary Meeting on Urological Cancers will take place in Barcelona, Spain, November 2nd to 4th, 2007. The meeting is co-organized by the European Association of Urology (EAU), the European Society for Medical Oncology (ESMO) and the European Society for Therapeutic Radiology and Oncology (ESTRO).
At the Annual Congress of the European Respiratory Society (ERS), which took place in Stockholm, September 15-19, 2007, researchers from the Imperial College London, UK, presented their study about the successful implantation of lung cells grown from embryonic stem cells into the lungs of mice. In future, this method could be used for the treatment of human lung diseases.